Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
41,788,098
-
Shares change
-
+1,219,818
-
Total reported value, excl. options
-
$2,317,550,403
-
Value change
-
+$69,379,349
-
Put/Call ratio
-
88%
-
Number of buys
-
88
-
Number of sells
-
-82
-
Price
-
$55.46
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2018
220 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2018.
REPLIGEN CORP - COMMON STOCK (RGEN) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41,788,098 shares
of 56,222,082 outstanding shares and own 74% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,212,759 shares), Vanguard Group Inc (3,923,135 shares), Invesco Ltd. (2,315,707 shares), OppenheimerFunds, Inc. (2,238,711 shares), Conestoga Capital Advisors, LLC (1,941,212 shares), STATE STREET CORP (1,830,180 shares), WELLINGTON MANAGEMENT GROUP LLP (1,445,251 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,363,109 shares), MACQUARIE GROUP LTD (1,194,430 shares), and DIMENSIONAL FUND ADVISORS LP (1,073,887 shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.